Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
Intrinsic Value
The intrinsic value of one Sichuan Kelun-Biotech Biopharmaceutical Co Ltd stock under the Base Case scenario is 162.72 HKD. Compared to the current market price of 285.4 HKD, Sichuan Kelun-Biotech Biopharmaceutical Co Ltd is Overvalued by 43%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
Fundamental Analysis


Revenue & Expenses Breakdown
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
Balance Sheet Decomposition
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
Current Assets | 3.5B |
Cash & Short-Term Investments | 3.1B |
Receivables | 306.6m |
Other Current Assets | 117.4m |
Non-Current Assets | 775.2m |
PP&E | 758.1m |
Intangibles | 2.6m |
Other Non-Current Assets | 14.5m |
Free Cash Flow Analysis
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
CNY | |
Free Cash Flow | CNY |
Earnings Waterfall
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
Revenue
|
1.9B
CNY
|
Cost of Revenue
|
-659.4m
CNY
|
Gross Profit
|
1.3B
CNY
|
Operating Expenses
|
-1.4B
CNY
|
Operating Income
|
-160.2m
CNY
|
Other Expenses
|
-106.6m
CNY
|
Net Income
|
-266.8m
CNY
|
Profitability Score
Profitability Due Diligence
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd's profitability score is 33/100. The higher the profitability score, the more profitable the company is.
Score
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd's profitability score is 33/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Score
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd is 274.63 HKD with a low forecast of 202.1 HKD and a high forecast of 369.84 HKD.
Dividends
Current shareholder yield for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one Sichuan Kelun-Biotech Biopharmaceutical Co Ltd stock under the Base Case scenario is 162.72 HKD.
Compared to the current market price of 285.4 HKD, Sichuan Kelun-Biotech Biopharmaceutical Co Ltd is Overvalued by 43%.